雄激素阻断对膀胱癌UM-UC-3细胞自噬与凋亡的影响
Effect of androgen blockade on autophagy and apoptosis in bladder cancer UM-UC-3 cells

DOI: 10.6040/j.issn.1671-7554.0.2017.251

Keywords: 膀胱癌,雄激素受体,自噬,比卡鲁胺,凋亡,
Bladder cancer,Bicalutamide,Apoptosis,Androgen receptor,Autophagy

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3]	Wu JT, Han BM, Yu SQ, et al. Androgen receptor is a potential therapeutic target for bladder cancer[J]. Urology, 2010, 75(4): 820-827.
[4]	Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation[J]. Science, 2000, 290(5497): 1717-1721.
[5]	Izumi K, Taguri M, Miyamoto H, et al. Androgen deprivation therapy prevents bladder cancer recurrence[J]. Oncotarget, 2014, 5(24): 12665-12674.
[6]	Hsu JW, Hsu I, Xu D, et al. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor[J]. Am J Pathol, 2013, 182(5): 1811-1820.
[7]	Bauckman KA, Mysorekar IU. Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells[J]. Autophagy, 2016, 12(5): 850-863.
[8]	Ojha R, Singh SK, Bhattacharyya S, et al. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent[J]. J Urol, 2014, 191(6): 1889-1898.
[9]	Huang YT, Cheng CC, Lin TC, et al. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells[J]. Oncol Rep, 2014, 31(2): 771-780.
[10]	Zhuang YH, Bl？uer M, Tammela T, et al. Immunodetection of androgen receptor in human urinary bladder cancer[J]. Histopathology, 1997, 30(6): 556-562.
[11]	Mir C, Shariat SF, van der Kwast TH,et al. Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study[J]. BJU Int, 2011, 108(1): 24-30.
[12]	Lin YC, Lin JF, Wen SI, et al. Inhibition of high basal level of autophagy induces apoptosis in human bladder cancer cells[J]. J Urol, 2016, 195(4): 1126-1135.
[13]	Shi Y, Han JJ, Tennakoon JB, et al. Androgens promote prostate cancer cell growth through induction of autophagy[J]. Mol Endocrinol, 2013, 27(2): 280-295.
[14]	Shiota M, Takeuchi A, Yokomizo A, et al. Androgen receptor signaling regulates cell growth and vulnerability to Doxorubicin in bladder cancer[J]. J Urol, 2012, 188(1): 276-286.
[15]	殷雷, 殷睿, 李文, 等. CYLD抑制自噬提高膀胱癌细胞吉西他滨化疗敏感性[J].山东大学学报(医学版), 2016, 54(11): 1-6. YIN Lei, YIN Rui, LI Wen, et al. CYLD improves bladder cancer gemcitabine chemosensitivity via suppressing autophagy[J]. Journal of Shandong University(Health Sciences), 2016, 54(11): 1-6.
[16]	Miyamoto H, Yang Z, Chen YT, et al. Promotion of bladder cancer development and progression by androgen receptor signals[J]. J Natl Cancer Inst, 2007, 99(7): 558-568.
[17]	Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy(3rd edition)[J]. Autophagy, 2016, 12(1): 1-222.
[18]	Jitao W, Jinchen H, Qingzuo L, et al. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition[J]. Andrologia, 2014, 46(10): 1128-1133.
[19]	Mashhadi R, Pourmand G, Kosari F, et al. Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study[J]. Urol J, 2014, 11(6): 1968-1973.
[20]	Mari？o G, Nisosantano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis[J]. Nat Rev Mol Cell Bio, 2014,15(2): 81-94.
[21]	Zeng LP, Hu ZM, Li K, et al. miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells[J]. J Cell Mol Med, 2016, 20(3): 559-567.
[22]	Boutin B, Tajeddine N, Vandersmissen P, et al. Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone-resistant prostate cancer cells and confer resistance to apoptosis[J]. Prostate, 2013, 73(10): 1090-1102.
[23]	Jiang Q, Yeh S, Wang X, et al. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy[J]. J Urol, 2012, 188(4): 1361-1368.
[24]	Jing Y, Cui D, Guo W, et al. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition[J]. Cancer Lett, 2014, 348(1-2): 135-145.
[25]	崔玉朋, 吴吉涛, 冯帆, 等. 雄激素受体基因对人膀胱癌T24细胞黏附和侵袭力的影响[J]. 中华实验外科杂志, 2013, 30(5): 1007-1009. CUI Yupeng, WU Jitao, FENG Fan, et al. Effects of androgen receptor gene on adhesion and invasion of human bladder cancer T24 cells[J]. Chin J Exp Surg, 2013, 30(5): 1007-1009.
[26]	Kawahara T, Ide H, Kashiwagi E, et al. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth[J]. Urol Oncol, 2016, 34(10): 432.e15-23.
[27]	Li JR, Cheng CL, Yang CR, et al. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux[J]. Toxicol Lett, 2013, 220(3): 267-276.

Full-Text